Novobiocin and Additional Inhibitors of the Hsp90 C-Terminal Nucleotide- binding Pocket

E-ISSN： 1875-533x|15|26|2702-2717

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.15, Iss.26, 2008-11, pp. : 2702-2717

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Geldanamycin, Radicicol, and Chimeric Inhibitors of the Hsp90 Nterminal ATP Binding Site

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 11, 2006-01 ,pp. : 1173-1182

Bentham Science Publishers

Access to resources Recommend Favorite

Macrocyclic Inhibitors of Hsp90

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 14, 2010-10 ,pp. : 1380-1402

Bentham Science Publishers

Access to resources Recommend Favorite

Medicinal Chemistry of Hsp90 Inhibitors

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 10, 2008-07 ,pp. : 859-868

Bentham Science Publishers

Access to resources Recommend Favorite

Purine-Scaffold Hsp90 Inhibitors

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 15, 2009-11 ,pp. : 1436-1446

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery and development of purine-scaffold Hsp90 inhibitors

By Chiosis Gabriela Kang Yanlong Sun Weilin

Expert Opinion on Drug Discovery, Vol. 3, Iss. 1, 2008-01 ,pp. : 99-114

Informa Healthcare

Access to resources Recommend Favorite